Angela Glading, Ph.D.

Angela Glading, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 711
Rochester, NY 14642

Office: (585) 273-5750
Lab: (585) 273-3043
Fax: (585) 273-2652

Journal Articles

Showing all 16 journal articles available.

DiStefano PV, Smrcka AV, Glading AJ. "Phospholipase C? Modulates Rap1 Activity and the Endothelial Barrier." PloS one. 2016 11(9):e0162338. Epub 2016 Sep 09.
Sarelius IH, Glading AJ. "Control of vascular permeability by adhesion molecules." Tissue barriers. 2015 3(1-2):e985954. Epub 2015 Apr 03.
2012 Nov
Corr M, Lerman I, Keubel JM, Ronacher L, Misra R, Lund F, Sarelius IH, Glading AJ. "Decreased Krev interaction-trapped 1 expression leads to increased vascular permeability and modifies inflammatory responses in vivo." Arteriosclerosis, thrombosis, and vascular biology. 2012 Nov; 32(11):2702-10. Epub 2012 Aug 23.
Glading AJ, Ginsberg MH. "Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling." Disease models & mechanisms. 2010 3(1-2):73-83. Epub 2009 Dec 09.
2007 Oct 22
Glading A, Han J, Stockton RA, Ginsberg MH. "KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions." The Journal of cell biology. 2007 Oct 22; 179(2):247-54.
2007 Feb 15
Glading A, Koziol JA, Krueger J, Ginsberg MH. "PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2." Cancer research. 2007 Feb 15; 67(4):1536-44.
2005 Aug
Krueger J, Chou FL, Glading A, Schaefer E, Ginsberg MH. "Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation." Molecular biology of the cell. 2005 Aug; 16(8):3552-61. Epub 2005 May 25.
2005 Mar
Satish L, Blair HC, Glading A, Wells A. "Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain." Molecular and cellular biology. 2005 Mar; 25(5):1922-41.
2004 Mar
Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, Potter DA, Blair HC, Wells A. "Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation." Molecular and cellular biology. 2004 Mar; 24(6):2499-512.
2003 Dec 26
Chou FL, Hill JM, Hsieh JC, Pouyssegur J, Brunet A, Glading A, Uberall F, Ramos JW, Werner MH, Ginsberg MH. "PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation." The Journal of biological chemistry. 2003 Dec 26; 278(52):52587-97. Epub 2003 Sep 23.
2002 Apr
Shiraha H, Glading A, Chou J, Jia Z, Wells A. "Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain." Molecular and cellular biology. 2002 Apr; 22(8):2716-27.
2002 Jan
Glading A, Lauffenburger DA, Wells A. "Cutting to the chase: calpain proteases in cell motility." Trends in cell biology. 2002 Jan; 12(1):46-54.
2001 Jun 29
Glading A, Uberall F, Keyse SM, Lauffenburger DA, Wells A. "Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling." The Journal of biological chemistry. 2001 Jun 29; 276(26):23341-8. Epub 2001 Apr 23.
2000 Jan 28
Glading A, Chang P, Lauffenburger DA, Wells A. "Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway." The Journal of biological chemistry. 2000 Jan 28; 275(4):2390-8.
1999 Jul 12
Shiraha H, Glading A, Gupta K, Wells A. "IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity." The Journal of cell biology. 1999 Jul 12; 146(1):243-54.
1998 Dec 1
Wells A, Gupta K, Chang P, Swindle S, Glading A, Shiraha H. "Epidermal growth factor receptor-mediated motility in fibroblasts." Microscopy research and technique. 1998 Dec 1; 43(5):395-411.